Herein, we examined the gene-expression profiles of peripheral blood CD4+ T cells in 28 treatment-naïve RA patients before and after MTX treatment and evaluated the roles of one of the differentially expressed genes, semaphorin 3G (Sema3G), in murine experimental arthritis models. This evidence concerns the gene SEMA3G and arthritic joint disease.